4//SEC Filing
Easom Eric 4
Accession 0000899243-23-006150
CIK 0001880438other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:36 PM ET
Size
5.3 KB
Accession
0000899243-23-006150
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-23+267,650→ 267,650 totalExercise: $11.99Exp: 2033-02-22→ Common Stock (267,650 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001914503
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:36 PM ET
- Size
- 5.3 KB